Respiratory

This learning programme aims to enable you to interpret and apply clinical guidance to support people living with COPD. You will consider how to optimise their treatment and use a person-centred approach to empower people living with COPD to self-manage their condition.

Learning Outcomes:

On completion of all aspects of this learning programme you should be able to:

• identify red flag signs and symptoms presenting in people living with COPD, who may require referral to another healthcare professional
• create a list of local resources to enable you to support and signpost people living with COPD
• discuss the options for the management of breathlessness and anxiety for people living with more advanced disease
• interpret clinical guidance and apply it in practice to support the optimisation of therapy for people living with COPD
• support people to self-manage their COPD while demonstrating a person-centred approach.

The aim of this programme is to develop your skills and confidence in supporting people to optimise their adherence to medicines in asthma. You will consider how to identify non-adherence, the different types of non-adherence and how to use a person-centred approach to optimise adherence through personalised interventions.

Learning Outcomes:

On completion of all aspects of this learning programme you should be able to:

• describe the scale and consequences of medicines non-adherence in asthma
• identify different methods of detecting non-adherence in asthma
• categorise different types of medicines non-adherence
• apply a shared decision making approach to discussions on adherence
• demonstrate approaches to overcome barriers and optimise adherence through personalised interventions.

The aim of this e-course is to improve your knowledge and skills in respiratory therapeutics. This will enable you to provide a person-centred approach to support the healthcare of people living with respiratory disease.

To facilitate your learning, we have structured the course into eight units. Some units are larger than others, but we estimate that you will need to commit an average of three hours of learning for each unit.

• Unit 1 – Introduction to the respiratory system
• Unit 2 – Inhaler technique and nebuliser use
• Unit 3 – Common respiratory conditions
• Unit 4 – Asthma
• Unit 5 – Chronic obstructive pulmonary disease (COPD)
• Unit 6 – Cystic fibrosis (CF)
• Unit 7 – Tuberculosis (TB)
• Unit 8 – Interstitial lung disease (ILD)

Learning Outcomes:

• describe and explain the core anatomy and function of the respiratory system
• describe the role of a pharmacy professional in supporting someone with respiratory disease
• identify sources of information to support people living with respiratory disease
• demonstrate a holistic, person-centred approach to the care of people living with respiratory disease
• apply safe and appropriate medicines optimisation for people with respiratory disease
• use current respiratory guidelines and standards to support evidence-based decisions around the treatment of respiratory disease.

In this e-learning programme we explore the reasons why we need to improve the way that we help people with their inhaler devices. We will look at how the devices work and why making simple changes when we are speaking to people using inhaled medicines can improve health outcomes.

Top image credit: IPCRG

Learning Outcomes:

• discuss the potential implications of sub-optimal inhaler technique
• describe the different types of inhaler devices and their instructions for use
• outline how the delivered dose is made in each type of device
• describe how inspiratory flow can affect medicine delivery for different inhalers
• describe the breathing technique required to achieve optimum inspiratory flow for each device
• describe how the environmental impact of inhalers effects prescribing decisions
• demonstrate your role in optimising inhaled medication.

This video learning (developed by Gráinne d’Ancona, consultant pharmacist for respiratory medicine at Guy’s and St Thomas’ NHS Foundation Trust) aims to increase your knowledge on the scale and consequences of medicines non-adherence in asthma. It explains what drives non-adherence, and will show you how to detect it. After watching, you should be able to implement tailored, structured interventions to support better adherence and ultimately improve patient care and outcomes.

The aim of this learning programme is to update your knowledge on the use of drugs for nebulisation in asthma and COPD and to enable you to support healthcare professionals and patients with respiratory disease to use nebulisers effectively.

Please note: this e-learning programme has been developed and provided by the Northern Ireland Centre for Pharmacy Learning and Development (NICPLD). Users should recognise that this programme will refer to Northern Ireland's policies and organisations. After ordering this programme, you will be redirected to their website where the resource is hosted. Please be aware that CPPE does not maintain control over the accuracy and currency of this programme.

Learning Outcomes:

On completion of all aspects of this learning programme you should be able to:

• list the drugs available for nebulisation in asthma and COPD
• outline the indications for nebuliser therapy in asthma and COPD
• describe the different types of nebuliser available
• advise on the use and maintenance of nebulising equipment.

This e-assessment is linked with the CPPE Chronic obstructive pulmonary disease focal point programme and assesses you on the learning outcomes within that programme.

Why should I do this assessment?

This e-assessment is linked with the CPPE Fundamentals of respiratory therapeutics e-learning programme and assesses you on the learning outcomes from unit 4 – Asthma within that programme.

Why should I do this assessment?

This e-assessment completes the learning you began with the asthma unit of the CPPE Fundamentals of respiratory therapeutics e-course. Access and successful completion will contribute to your own personal development plan, be recorded in your My CPPE record and will enable you to complete a CPD entry on the learning. It may also provide evidence for achieving competencies in the RPS Foundation or Advanced Pharmacy Frameworks. If you are working towards completing a Declaration of Competence for a pharmacy service, successful completion of this assessment will provide evidence of your learning. 

This e-assessment is linked with the CPPE Inhaler technique for health professionals: getting it right e-learning programme and assesses you on the learning outcomes within that programme.

Why should I do this assessment?

Information & learning to support Pharmacy Quality Scheme(PQS). From this page you will find out what is required for you and your team to meet the respiratory domain. With links to CPPE learning for inhaler technique & Community Pharmacy England (formally PSNC) for return of unwanted & used inhalers.

The Primary Care Respiratory Society (PCRS) is an organisation that supports all healthcare professionals to work together to support optimal holistic patient-centred care and outcomes for people living with respiratory disease. Resources, webinars & videos on respiratory related topics including Asthma, COPD, tobacco dependency, Covid-19 and inhaler devices.

This page brings together all the PrescQIPP respiratory care resources and campaign materials as well as showcase good practice examples of projects in respiratory care and signpost to self care resources available for organisations to use to support their own respiratory care campaigns.

The Greener Practice, High Quality and Low Carbon Asthma Care toolkit has been designed to support primary care improve asthma care while reducing carbon emissions. The toolkit also provides step by step support for quality improvement projects.

Evidence-based strategy document for COPD diagnosis, management, and prevention, with citations from the scientific literature.

BTS & SIGN have worked in partnership since 2001 to produce the British Guideline on the Management of Asthma. The current addition (July 2019) can be found via this link.